tiprankstipranks
reAlpha Tech Corp. (AIRE)
NASDAQ:AIRE
US Market

reAlpha Tech Corp. (AIRE) Stock Price & Analysis

108 Followers

AIRE Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$0.53 - $575.41
Previous Close$1.04
Volume560.42K
Average Volume (3M)3.16M
Market Cap
$45.89M
Enterprise Value$50.48M
Total Cash (Recent Filing)$1.26M
Total Debt (Recent Filing)$5.85M
Price to Earnings (P/E)N/A
Beta1.67
Apr 19, 2024
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding44,122,091
10 Day Avg. Volume3,334,476
30 Day Avg. Volume3,155,748
Standard Deviation0.38
R-Squared0.18
Alpha-0.15
Financial Highlights & Ratios
Price to Book (P/B)6.21
Price to Sales (P/S)109.41
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit400.00
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

Options Prices

Currently, No data available
---

Ownership Overview

0.00%0.27%0.17%99.56%
0.00%
Insiders
0.17% Other Institutional Investors
99.56% Public Companies and
Individual Investors

AIRE FAQ

What was reAlpha Tech Corp.’s price range in the past 12 months?
reAlpha Tech Corp. lowest stock price was $0.53 and its highest was $575.41 in the past 12 months.
    What is reAlpha Tech Corp.’s market cap?
    Currently, no data Available
    When is reAlpha Tech Corp.’s upcoming earnings report date?
    reAlpha Tech Corp.’s upcoming earnings report date is Apr 19, 2024 which is 25 days ago.
      How were reAlpha Tech Corp.’s earnings last quarter?
      Currently, no data Available
      Is reAlpha Tech Corp. overvalued?
      According to Wall Street analysts reAlpha Tech Corp.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does reAlpha Tech Corp. pay dividends?
        reAlpha Tech Corp. does not currently pay dividends.
        What is reAlpha Tech Corp.’s EPS estimate?
        reAlpha Tech Corp.’s EPS estimate for its next earnings report is not yet available.
        How many shares outstanding does reAlpha Tech Corp. have?
        reAlpha Tech Corp. has 44,122,090 shares outstanding.
          What happened to reAlpha Tech Corp.’s price movement after its last earnings report?
          Currently, no data Available
          Which hedge fund is a major shareholder of reAlpha Tech Corp.?
          Currently, no hedge funds are holding shares in AIRE
          ---

          reAlpha Tech Corp. Stock Smart Score

          Company Description

          reAlpha Tech Corp.

          Bio-Techne Corporation is a global life sciences company. The Company is engaged in providing tools and bioactive reagents for the research and clinical diagnostic communities. It operates through two segments: Protein Sciences and Diagnostics and Genomics. Its Protein Sciences segment develops and manufactures biological reagents used in all aspects of life science research, diagnostics and cell and gene therapy. This segment also includes proteomic analytical tools, both manual and automated, that offer researchers and pharmaceutical manufacturers efficient and streamlined options for automated western blot and multiplexed ELISA workflow. The Diagnostics and Genomics segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for the regulated diagnostics market, exosome-based molecular diagnostic assays, advanced tissue-based in-situ hybridization assays for spatial genomic and tissue biopsy analysis, and genetic and oncology kits.
          ---
          Similar Stocks
          Company
          Price & Change
          Follow
          Ashford Hospitality
          Alphabet Class A
          Microsoft
          Popular Stocks
          ---
          What's Included in PREMIUM?
          Make informed decisions based on Top Analysts' activity
          Know what industry insiders are buying
          Get actionable alerts from top Wall Street Analysts
          Find out before anyone else which stock is going to shoot up
          Get powerful stock screeners & detailed portfolio analysis